Scoulerine
CAS No. 6451-73-6
Scoulerine( (-)-Scoulerine | Discretamine )
Catalog No. M29229 CAS No. 6451-73-6
Scoulerine is an inhibitor of -site amyloid precursor protein cleaving enzyme 1(BACE1). Scoulerine a potent antimitotic compound that inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 155 | In Stock |
|
| 10MG | 275 | In Stock |
|
| 25MG | 465 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameScoulerine
-
NoteResearch use only, not for human use.
-
Brief DescriptionScoulerine is an inhibitor of -site amyloid precursor protein cleaving enzyme 1(BACE1). Scoulerine a potent antimitotic compound that inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.
-
DescriptionScoulerine is an inhibitor of -site amyloid precursor protein cleaving enzyme 1(BACE1). Scoulerine a potent antimitotic compound that inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.(In Vitro):Scoulerine shows significant cytotoxic effects against both two cancer cell lines (Caco-2 and Hep-G2 cancer cells), with IC50 values 6.44 ± 0.87 and 4.57 ± 0.42, respectively. Scoulerine shows antiplasmodial activity with IC50 values of 5.4 μM and 3.1 μM against the antifolate sensitive and the multidrug resistant P. falciparum strains: TM4/8.2 and K1CB1, respectively.
-
In VitroScoulerine ((-)-Scoulerine) inhibits mini-panel of human leukemic cells, MOLT-4 (WT), Jurkat (TP53 mutated), Raji (TP53 mutated), HL-60 (TP53 null), U-937 (TP53 mutated), and HEL 92.1.7 (wild-type), with IC50s ranging from 2.7?μM to 6.5?μM.Scoulerine (2.5-20?μM; 24 hours) decreases proliferation of Jurkat and MOLT-4 cells.Scoulerine (2.5-20?μM; 24 hours) induces MOLT-4 and Jurkat cells apoptosis.Scoulerine induces G2 or M cell cycle arrest.Scoulerine (2.5-5?μM; 24?hours) shows an upregulation of p53 protein in p53 wild-type MOLT-4 cells.Scoulerine (2.5-5?μM; 24-48 hours) activates caspase-3/7, -8 and -9 in a dose-dependent manner.Scoulerine (5-10 μM; 24 hours) disrupts microtubule structure of A549 lung carcinoma cells .Cell Proliferation Assay Cell Line:Jurkat and MOLT-4 cellsConcentration:2.5, 5, 10, 15 and 20?μM Incubation Time:24?hours Result:Significantly reduced the viability and proliferation of Jurkat and MOLT-4 cells in a dose dependent manner.Apoptosis Analysis Cell Line:MOLT-4 and Jurkat cells Concentration:2.5, 5, 10, 15 and 20?μM Incubation Time:24 hours Result:Induced MOLT-4 and Jurkat cells apoptosis.Cell Cycle Analysis Cell Line:Jurkat and MOLT-4 leukemic cells Concentration:2.5-20 μM Incubation Time:16 hours Result:Induced cell cycle arrest at the G2/M transition.Western Blot Analysis Cell Line:MOLT-4 cells Concentration:2.5, 5?μM Incubation Time:24?hours Result:Showed an upregulation of p53 protein in p53 wild-type MOLT-4 cells.
-
In Vivo——
-
Synonyms(-)-Scoulerine | Discretamine
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6451-73-6
-
Formula Weight327.38
-
Molecular FormulaC19H21NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (305.46 mM)
-
SMILESCOc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(OC)c4O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
SACLAC
SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
D609
D609 (Tricyclodecan-9-yl-Xanthogenate) has a wide range of biological activities including antioxidant, antiapoptotic, anticholinergic, antitumor, anti-inflammatory, antiviral, antiproliferative, and neuroprotective activities.
-
BTT-3033
BTT-3033 is an orally active and potent α2β1 (EC50: 130 nM) inhibitor with an affinity for the α2I domain, inhibiting platelet binding to collagen I and cell proliferation.
Cart
sales@molnova.com